C000175520 Performance — Patient Opportunity Trust, Class C
Data updated: 2024-03-15
C000175520 returned +38.10% over one year to Dec 2023. The annualised 3-year return is −5.60%. Against its US Multi-Cap Growth category average the fund came out behind over three years but ahead over one: $100 invested three years ago grew to $84, against $106 for the category, and to $138 over one year, against $126. Volatility over the past three years was 29.77% a year. In the 12 months to Dec 2023 the fund took in a net $2.7B, and assets reached $1.38B.
C000175520 Growth of $100
What $100 invested in Patient Opportunity Trust grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Multi-Cap Growth category average over the same months.
| Period | C000175520 | Category average |
|---|---|---|
| 1 year (Jan 2023 – Dec 2023) | $138 | $126 |
| 3 years (Jan 2021 – Dec 2023) | $84 | $106 |
| Since data start (Jul 2019 – Dec 2023) | $134 | $156 |
C000175520 Trailing Returns
Total returns to Dec 2023, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +38.10% |
| 3 years (annualised) | −5.60% |
C000175520 Annual Returns
Calendar-year total returns of Patient Opportunity Trust, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2023 | +38.10% |
| 2022 | −36.58% |
| 2021 | −3.96% |
| 2020 | +37.56% |
| 2019 (Jul–Dec) | +16.04% |
C000175520 Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | +20.8% | −4.6% | −4.5% | −2.0% | +2.2% | +13.2% | +7.8% | −8.0% | −5.3% | −8.3% | +13.6% | +13.2% |
| 2022 | −6.1% | −2.7% | +1.6% | −10.9% | −4.2% | −17.6% | +10.6% | +0.4% | −14.0% | +10.4% | +5.0% | −12.2% |
| 2021 | +7.9% | +7.5% | +0.4% | +3.6% | −0.8% | +1.1% | −6.0% | −4.4% | −4.6% | +2.0% | −7.0% | −2.3% |
| 2020 | −2.6% | −11.6% | −29.2% | +23.8% | +7.7% | +10.4% | +9.6% | +9.4% | −5.7% | −0.5% | +24.1% | +9.8% |
| 2019 | — | — | — | — | — | — | +2.5% | −7.9% | +3.7% | +7.3% | +9.4% | +0.9% |
C000175520 Risk
Risk measures from monthly returns over Jan 2021 – Dec 2023.
- 3-year volatility (annualised): 29.77%
- 3-year Sharpe ratio: -0.34 (vs 4.5% risk-free rate)
- Best month: +20.77% (Jan 2023)
- Worst month: −17.59% (Jun 2022)
C000175520 Fund Flows
Monthly money in and out of Patient Opportunity Trust, from SEC Form N-PORT.
- 12-month net flow: $2.7B
- 12-month gross sales (incl. reinvestments): $1.3B
- Sales ÷ redemptions: -0.89×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Dec 2023 | $7.3M | −$22.0M | $29.2M |
| Nov 2023 | $7.8M | −$20.9M | $28.6M |
| Oct 2023 | $6.4M | −$29.3M | $35.7M |
| Sep 2023 | $4.8M | −$15.2M | $20.0M |
| Aug 2023 | $12.2M | −$20.7M | $32.9M |
| Jul 2023 | $5.4M | −$15.3M | $20.7M |
| Jun 2023 | $10.4M | −$24.3M | $34.7M |
| May 2023 | $1.2B | −$1.2B | $2.4B |
| Apr 2023 | $6.4M | −$17.0M | $23.5M |
| Mar 2023 | $10.2M | −$25.0M | $35.2M |
| Feb 2023 | $8.6M | −$32.5M | $41.1M |
| Jan 2023 | $16.4M | −$24.6M | $41.0M |
C000175520 Assets Under Management
Net assets of Patient Opportunity Trust by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2023-12-31 | $1.38B |
| 2023-09-30 | $1.22B |
| 2023-06-30 | $1.32B |
| 2023-03-31 | $1.20B |
| 2022-12-31 | $1.13B |
| 2022-09-30 | $1.21B |
| 2022-06-30 | $1.34B |
| 2022-03-31 | $1.97B |
| 2021-12-31 | $2.19B |
| 2021-09-30 | $2.41B |
| 2021-06-30 | $2.88B |
| 2021-03-31 | $2.69B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.